Medical Developments International Ltd (ASX:MVP)
A$ 0.44 -0.01 (-2.22%) Market Cap: 49.57 Mil Enterprise Value: 42.12 Mil PE Ratio: 0 PB Ratio: 0.85 GF Score: 58/100

Q3 2024 Medical Developments International Ltd Activities Report Call Transcript

Apr 29, 2024 / 01:30AM GMT
Release Date Price: A$0.516258 (-1.85%)
Brent MacGregor Medical Developments International Limited;CEO

Thank you and good morning, and welcome to today's investor briefing. Thanks to all of you for joining us on such short notice. I'm Brent MacGregor, I'm the CEO and I'm joined today by Anita James, our Chief Financial Officer.

So today's call is intended to provide you with an update on our quarterly performance and to give further context to the information in our quarterly activity report and our Appendix 4C for Q3 of FY24, which we released this morning to the market.

Today's release is the company's first quarterly report. The initiation of this quarterly reporting has been requested by the ASX due to our current cash position. That said, it provides us the opportunity to get more regular updates to the market on our progress and pathway to cash flow positivity and delivery of strategy.

I we'll now be opening the lines to questions at the end of today's call. However, we will be addressing several questions that we've received from the market that we believe encapsulate the key areas of inquiry for most

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot